Bayer

FDA grants breakthrough status to joint Merck-Bayer AI program
FDA grants breakthrough status to joint Merck-Bayer AI program
Mass Device
Merck
Bayer
FDA
breakthrough status
devices
CTEPH
artificial intelligence
Flag link:
In the wake of deep R&D cuts, Bayer flags safety concerns for a top PhIII drug
In the wake of deep R&D cuts, Bayer flags safety concerns for a top PhIII drug
Endpoints
Bayer
layoffs
R&D
vilaprisan
uterine fibroids
Flag link:
Bayer cuts 900 pharma jobs, turns focus to invest externally
Bayer cuts 900 pharma jobs, turns focus to invest externally
BioCentury
Bayer
layoffs
restructuring
Flag link:
Bayer Cuts 12,000 Jobs, Plans Vet-Unit Exit as Suits Weigh
Bayer Cuts 12,000 Jobs, Plans Vet-Unit Exit as Suits Weigh
Bloomberg
Bayer
layoffs
animal health
Flag link:
Shattering an old record, FDA quickly OKs pioneering, site-agnostic cancer drug larotrectinib from Loxo and Bayer
Shattering an old record, FDA quickly OKs pioneering, site-agnostic cancer drug larotrectinib from Loxo and Bayer
Endpoints
FDA
larotrectinib
Bayer
Loxo Oncology
oncology
personalized medicine
Flag link:
Cyclica Partners with Bayer to Advance its AI-Augmented Network of Cloud-Based Technologies
Cyclica Partners with Bayer to Advance its AI-Augmented Network of Cloud-Based Technologies
CP Wire
Cyclica
Bayer
artificial intelligence
Flag link:
Cyclica Partners with Bayer to Advance its AI-Augmented Network of Cloud-Based Technologies
Cyclica
Bayer
AI
Flag link:
Bayer Hurts from Generic Competition & Pipeline Setbacks
Bayer Hurts from Generic Competition & Pipeline Setbacks
Yahoo/Zacks.com
Bayer
Flag link:
Flat quarter for Bayer, shares drop 3%
Flat quarter for Bayer, shares drop 3%
GoinPharma
Bayer
earnings
Flag link:
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
CP Wire
Bayer
regorafenib
glioblastoma
Flag link:
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Bayer
regorafenib
glioblastoma
Flag link:
Bayer applies artificial intelligence to its pharmacovigilance systems
Bayer applies artificial intelligence to its pharmacovigilance systems
Pharmaforum
Bayer
patient safety data monitoring
patient safety
pharmacovigilance
artificial intelligence
Flag link:
Bayer plans filings for prostate cancer drug darolutamide
Bayer plans filings for prostate cancer drug darolutamide
Pharmaforum
Bayer
darolutamide
prostate cancer
Pfizer
JNJ
Flag link:
Loxo's targeted therapy holds up to Roche challenge
Loxo's targeted therapy holds up to Roche challenge
Biopharma Dive
Roche
entrectinib
Loxo Oncology
Ignyta
Bayer
larotrectinib
Flag link:
J&J snaps up key label expansion for Xarelto
J&J snaps up key label expansion for Xarelto
Biopharma Dive
JNJ
Xarelto
bloodthinners
Eliquis
Janssen
Bayer
Flag link:
Bayer considering sale of Animal Health business (€6-7bn)
Bayer considering sale of Animal Health business (€6-7bn)
GoinPharma
Bayer
animal health
M&A
Flag link:
Bayer Cutting More Than 200 Jobs in San Francisco Bay Area
Bayer Cutting More Than 200 Jobs in San Francisco Bay Area
Biopharma Dive
Bayer
layoffs
drug manufacturing
Flag link:
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Pharmaforum
UK
Roche
Avastin
wet age-related macular degeneration
Novartis
Bayer
Flag link:
New report re-ignites fresh buzz that Bayer is prepping an R&D overhaul and job cuts
New report re-ignites fresh buzz that Bayer is prepping an R&D overhaul and job cuts
Endpoints
Bayer
R&D
layoffs
Flag link:
LEO Pharma Closes Acquisition of Bayer’s Prescription Dermatology Business in the US
Bayer
LEO Pharma
Flag link:

Pages